Last 12 months
- December 2022 (0)
- November 2022 (1)
- October 2022 (1)
- September 2022 (1)
- August 2022 (1)
- July 2022 (2)
- June 2022 (1)
- May 2022 (0)
- April 2022 (0)
- March 2022 (2)
- February 2022 (3)
- January 2022 (1)
- Show All
- Infection (1)
- Day of Immunology (17)
- Competition (9)
- ASI Membership (24)
- Visiting Speaker Program (4)
- Immunology (100)
- Closing Soon (4)
- Journals (18)
- Special Interest Groups (3)
- Immunology & Cell Biology (24)
- Women's Initiative (10)
- ASI Awards (55)
- Clinical & Translational Immunology (9)
- ASI (90)
- Event/Meeting (42)
- Vaccines (32)
- Show All
Tuesday July 03, 2018
Another fantastic reason to submit to ICB and CTI
Today we announce a brand new initiative, the ICB and CTI Altmetric Awards. There are two awards, each valued at AUD 500.
The Altmetric Award rewards the publication with the highest Altmetric Attention Score.
What are Altmetrics?
Good question. Altmetrics complement traditional, citation-based metrics by measuring how widely discussed a journal article is around the globe.
It recognises other indicators of your paper’s success; the attention, influence, and impact.
So to all current and future authors of papers in ICB and CTI: For your best chance to win; tweet, write press releases, engage the media and tell your friends and colleagues to share.. Sharing is caring!
For more on Altmetrics, please click here.
The fine print
The following terms and conditions apply:
- There is one prize each for articles published in ICB and CTI per year beginning 1 July.
- The inaugural prize will be awarded for articles published from 1 July 2018 to 30 June 2019.
- The articles must be from a category that undergoes peer-review (e.g. original article, review).
- ‘Published’ is defined as having a DOI.
- All eligible articles will be automatically considered, including those by non ASI members
- The Altmetric Attention Score is recorded on the first business day of the month starting at least two months after publication. The business day is as determined in Melbourne, Australia.